Dr. James R. Berenson, MD Institute for Myeloma & Bone Cancer Research Interview date: September 6, 2013
On this week's show, Dr. James R. Berenson of the Institute for Myeloma & Bone Cancer Research discusses his unique approach to use myeloma therapies in a variety of combinations that looks at dosing, ordering and scheduling to both treat the myeloma while at the same time addressing quality of life issues. He discusses how resistance to one type of myeloma therapy doesn't necessarily mean resistance to others in that same drug class. He also discusses how his Institute and clinic enable him to investigate new targets in a shorter time frame. The live mPatient Myeloma Radio podcast with Dr. Berenson
Dr. Berenson founded the Institute for Myeloma & Bone Cancer Research (IMBCR) in 2003 and serves as its Medical and Scientific Director: A mission-driven 501(C)3 non-profit institute is committed to advance the monitoring and treatment of multiple myeloma (MM) by connecting possibility through scientific innovation leading to personalized and continuous optimized patient care. Dr. Berenson has authored nearly 300 peer-reviewed publications and contributed to multiple book chapters. He has served as a member of the National Institutes of Health – Center for Scientific Review, Clinical Oncology Study Section and is a member of the Scientific Boards of the Multiple Myeloma Research Foundation and the International Myeloma Foundation. Dr. Berenson has also served on both the Foundation and the Scientific Boards of the Leukemia, Lymphoma and Myeloma Society. Additionally, Dr Berenson is Section Editor for Supportive Cancer Therapy and on the Editorial Board of: Annals of Hematology, Annals of Oncology, British Journal of Hematology, Clinical Advances in Hematology & Oncology, Clinical Cancer Research, Clinical Lymphoma & Myeloma, Critical Reviews in Oncogenesis, Targeted Oncology, and provides Current Opinion in Supportive and Palliative Care.
Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
+1 800 709 1113
Support@healthtree.org
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.